Hemangeol 4.28 MG/ML oral soln 120ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCU9L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,663
Award facts
- Contract value 100% obligated
- $2,662.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Hemangeol 4.28 mg/mL oral solution (120 mL) with a ceiling value of $2,662.56. This is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide.
Hemangeol is a specialized cardiac medication used primarily for the treatment of infantile hemangioma, making this order part of AmerisourceBergen's extensive portfolio of pharmaceutical deliveries to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and other government medical programs. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen regularly fulfills competitive federal procurement requirements through its IDC with DLA, demonstrating proven capability to deliver specialized medical products across multiple therapeutic domains to support military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FCU9L?
SPE2DR26FCU9L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FCU9L worth?
The government has obligated $2,663 on SPE2DR26FCU9L.
Is contract SPE2DR26FCU9L an order under another contract?
Yes. SPE2DR26FCU9L is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCU9L competed?
The extent of competition for SPE2DR26FCU9L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award